• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Mastitis Companies

    ID: MRFR/Pharma/3936-CR
    142 Pages
    Rahul Gotadki
    July 2019

    Mastitis companies focus on innovative solutions for breast health. Specializing in research, development, and distribution, they provide advanced treatments, contributing to the prevention and management of mastitis, enhancing the well-being of breastfeeding individuals.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Mastitis Market

    Mastitis Key Companies

     


    Latest Mastitis Companies Update:

    Boehringer Ingelheim launched Galactomune® L, a new vaccine for preventing mastitis caused by Staphylococcus aureus.


    Zoetis introduced their VIMOTM (Veterinary Imaging and Milk Testing) system, offering real-time milk analysis and mastitis detection.


    DeLaval expanded its DelPro™ herd management software with advanced mastitis prediction and prevention tools.


    GEA Farm Technologies unveiled their DairyRobot R9500, a robotic milking system with integrated mastitis detection sensors.


    Emerging companies like Milkin' Bull and Udderly Precise are developing AI-powered udder health monitoring systems for early mastitis detection.


    List of Mastitis Key companies in the market

    • Bayer AG (Germany)

    • Oncothyreon Inc (US)

    • OncoGenex (US)

    • Apthera Inc. (UK)

    • Zoetis Inc. (US)

    • Boehringer Ingelheim GmbH (Germany)

    • Merck Co. & Inc. (US)

    • Astellas Pharma Inc. (Japan)

    • Pfizer Inc. (US)

    • Novartis AG (Switzerland)

    • Sanofi SA (France)

    • Hoffmann-La Roche AG (Switzerland)